- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
January 5th, 2005
As nanotechnology companies move into public markets, early stage companies may lack the revenue visibility usually accompanying startups in more established industries.
It is arguable that a platform technology-based nanotechnology company what well call pluripotent deserves a premium valuation: one that exceeds the value of its visible product line. But as shown by the withdrawn IPO of Nanosys an example of this type of company public investors may not see it this way.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016